Biocon Limited has informed the Exchange regarding a press release dated July 09, 2026, titled " Biocon Announces Publication of Pivotal Clinical Data Supporting Effectiveness of Yesafili , a Biosimilar to Eylea® (Aflibercept) ".
Biocon Limited has informed the Exchange regarding a press release dated July 09, 2026, titled " Biocon Announces Publication of Pivotal Clinical Data Supporting Effectiveness of Yesafili , a Biosimilar to Eylea® (Aflibercept) ".